News

27.02.2019 | Termin

15. DVMD-symposium

VPM will be present at the "15. DVMD-Fachtagung: Brücken bauen zwischen Medizin, Informatik, Biometrie und Epidemiologie" which will take place in Düsseldorf on 05-06 March, 2019.

26.02.2019 | Termin

VaxInLive 2019 Symposium

VPM will speak during the VaxInLive 2019 Symposium, that will take place at the University of Antwerp from 27th February until 1st March 2019.

12.02.2019 | Termin

Successful R&I in Europe 2019: 10th European Networking Event

VPM will be present at the "Successful R&I in Europe 2019: 10th European Networking Event" which will take place in Düsseldorf on 14-15 February, 2019.

06.02.2019 | Termin

ATMPS: Early Phase Regulatory Requirements and Interactions

VPM will speak during a Rebirth special lecture, that will take place in the Hannover Medical School (Lecture Hall M,I1) on 12. February 2019, 5:00 pm. 

06.02.2019 | News

TBVI (TuBerculosis Vaccine Initiative) Annual Symposium 2019

VPM was invited to join the TBVI (TuBerculosis Vaccine Initiative) Annual Symposium which was held on 29th of January until 31th of January 2019 in Les Diablerets, Switzerland.

01.02.2019 | News

priMe Consortium Kick-Off Meeting

From 28. to 29.11.2018, VPM organized a kick off meeting in Johannesburg, South Africa, for a pivotal VPM1002 phase III trial to be conducted in newborn infants in South Africa, Tanzania, Kenya, Uganda and Gabon.

08.08.2018 | Termin

11th International VPM Days

This year's conference topic is "15 Years VPM - from Target to Market". The presentations during the event will address critical factors for successful translational research and development.

14.06.2018 | Termin

Qualitätsmanagement in kleinen Organisationseinheiten

Richtig aufgestellt für klinische Prüfungen gemäß ICH GCP - erfahren Sie in diesem Seminar, wie es funktioniert!

12.03.2018 | Pressemeldung

2018 PDA Europe Vaccines

VPM spricht auf der Konferenz 2018 PDA Europe Vaccines in Málaga, Spanien vom 24.-25. April 2018.

12.03.2018 | Pressemeldung

EAU18 Copenhagen

Erste Ergebnisse der klinischen Phase I/II Studie zur Untersuchung des neuen Medikaments VPM1002BC werden auf dem internationalen Kongress der European Association of Urology 2018 in Kopenhagen, Dänemark vom 16.-20. März präsentiert.